Drugs / OPC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03092635 | Jun 2017 → Nov 2021 | breast cancer | Medical University of South Carolina | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OPC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03092635 ↗ |
| Route | Oral | “subjects will take one OPC tablet in the morning and in the evening” NCT03092635 ↗ |